Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Medicine|July 14, 2023
Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature reviewAkane Ariga, Seiichi Matsumoto, Taisuke Tanizawa, et al.
Japanese Journal of Clinical Oncology|March 1, 2015
Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE studyKenji Nakano, Noriko Motoi, Lina Inagaki, et al.
International Journal of Clinical Oncology|March 1, 2008
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor geneNaohiro Izawa, Seiichi Matsumoto, Jun Manabe, et al.
Anticancer Research|January 9, 2021
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue SarcomaYasuyoshi Sato, Kenji Nakano, Naoki Fukuda, et al.
Cureus|January 21, 2025
Gemcitabine-Based Chemotherapy for Advanced Soft Tissue Sarcoma: Identifying the Appropriate Dose and ScheduleKenji Nakano, Naomi Hayashi, Xiofei Wang, et al.
Molecular and Clinical Oncology|December 7, 2020
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment lineKenji Nakano, Keiko Hayakawa, Yuki Funauchi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue SarcomaYasuyoshi Sato, Kenji Nakano, Kuniki Kawaguchi, et al.
Cancers|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue SarcomaYasuyoshi Sato, Kenji Nakano, Xiaofei Wang, et al.
Oncology|January 31, 2022
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk OriginKenji Nakano, Naoki Fukuda, Yasuyoshi Sato, et al.
Oncology Letters|January 8, 2025
Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case reportTetsuya Urasaki, Makiko Ono, Kyoko Yamashita, et al.
Pageof 6